Sabine Spath
Head of Preclinical Operations
Research Interests
Explore related searches
Contact this professor
Get a free first email built on one of their papers, ready for you to edit and send yourself.
About
Dr. Sabine Spath is the Head of Preclinical Operations at InCephalo, Switzerland. Her research interests focus on the immunological mechanisms influencing cancer therapy and intestinal inflammation, as highlighted in her recent articles. Dr. Spath's work explores the roles of various immune cell types and molecular pathways in conditions such as glioblastoma and autoimmune diseases.
Articles (5)
Year:
2025
Year:
2024
Year:
2024
Differing from the mouse Foxp3 gene that encodes only one protein product, human FOXP3 encodes two major isoforms through alternative splicing—a longer isoform (FOXP3 FL) containing all the coding exons and a shorter isoform lacking the amino acids encoded by exon 2 (FOXP3 ΔE2). The two isoforms are naturally expressed in humans, yet their differences in controlling regulatory T cell phenotype and functionality remain unclear. In this study, we show that patients expressing only the shorter isoform fail to maintain self-tolerance and develop immunodeficiency, polyendocrinopathy, and enteropathy X-linked (IPEX) syndrome. Mice with Foxp3 exon 2 deletion have excessive follicular helper T (T FH ) and germinal center B (GC B) cell responses, and develop systemic autoimmune disease with anti-dsDNA and antinuclear autoantibody production, as well as immune complex glomerulonephritis. Despite having normal suppressive function in in vitro assays, regulatory T cells expressing FOXP3 ΔE2 are unstable and sufficient to induce autoimmunity when transferred into Tcrb -deficient mice. Mechanistically, the FOXP3 ΔE2 isoform allows increased expression of selected cytokines, but decreased expression of a set of positive regulators of Foxp3 without altered binding to these gene loci. These findings uncover indispensable functions of the FOXP3 exon 2 region, highlighting a role in regulating a transcriptional program that maintains T reg stability and immune homeostasis.
Year:
2022
Year:
2022
Collaborators (6)
Johannes vom Berg
University of Zurich
Steven Ziegler
-
Jack Rohrer
Group Leader/Full Professor
Zurich University of Applied Sciences (ZHAW)
Gregor Hutter
-
Baohua Zhou
Indiana University School of Medicine
Phillip Domeier
Assistant Professor
The University of British Columbia
Make your next move.
Prepare your application
Review drafts before you send them.